Dong Quehuong (Kathy) reported ETRA

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002153364-26-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 21, 2026

Published

Sep 21, 2026

Ingested by INSIDER

Nov 5, 02:16 UTC

Last re-read

Nov 5, 02:16 UTC

Extracted facts

Filer

Dong Quehuong (Kathy)

Role

Director, President & CEO

Transaction

Derivative conversionAs filed: “C”

Asset

Electra Therapeutics, Inc. — Series A Convertible Preferred Stock

Ticker

ETRA

Shares

455.5K

Execution date (reported)

Sep 21, 2026

Owned after transaction

0 shares

Days from execution to publication

0

What this establishes

Dong Quehuong (Kathy) filed this Form 4 reporting a derivative conversion of ETRA on Sep 21, 2026. It became public on Sep 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, President & CEO

Dong Quehuong (Kathy)cik:0002153364

Issuer

Electra Therapeutics, Inc.cik:0002088082

Revision history · 0

No field has changed since this record was first ingested.